Sandler Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Sell |
15,915
-25,867
| -62% | -$2.78M | 0.46% | 76 |
|
|
2025
Q1 | $4.21M | Buy |
41,782
+6,605
| +19% | +$666K | 1.05% | 26 |
|
|
2024
Q4 | $3.14M | Sell |
35,177
-21,062
| -37% | -$1.88M | 0.33% | 80 |
|
|
2024
Q3 | $4.71M | Buy |
56,239
+4,267
| +8% | +$358K | 0.62% | 48 |
|
|
2024
Q2 | $4M | Sell |
51,972
-20,270
| -28% | -$1.56M | 0.43% | 54 |
|
|
2024
Q1 | $4.95M | Sell |
72,242
-334,670
| -82% | -$22.9M | 0.36% | 67 |
|
|
2023
Q4 | $23.5M | Buy |
406,912
+22,233
| +6% | +$1.29M | 1.95% | 4 |
|
|
2023
Q3 | $20.3M | Sell |
384,679
-112,079
| -23% | -$5.92M | 2.09% | 5 |
|
|
2023
Q2 | $26.9M | Buy |
496,758
+143,645
| +41% | +$7.77M | 2.21% | 8 |
|
|
2023
Q1 | $17.7M | Buy |
+353,113
| New | +$17.7M | 1.61% | 10 |
|